Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy
Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy
Recruiting · NCT06826092 · Registry updated 2025-02-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin for the Treatment of mCRC Patients Undergoing FOLFIRI Plus Target Therapy | Progression-Free Survival | Recruiting | Phase 2 | 2025-02-13 | NCT06826092 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Kaohsiung Medical University Chung-Ho Memorial Hospital | 56 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chung-Ho Memorial Hospital, Kaohsiung Medical University: | Kaohsiung City | Taiwan | 1 |